Also written by Tracon Pharmaceuticals, Inc.:
TRACON Pharmaceuticals Appoints Stephen Worland to Its Board of Directors
x hide permanently

TRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors


SAN DIEGO, TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today the appointment of Carol Lam to its Board of Directors...

Mentions: Attorneys Nasdaq Women